nodes	percent_of_prediction	percent_of_DWPC	metapath
Gefitinib—SBK1—endometrium—vaginal cancer	0.0287	0.0287	CbGeAlD
Gefitinib—HIPK4—female reproductive system—vaginal cancer	0.0235	0.0235	CbGeAlD
Gefitinib—CHEK2—female gonad—vaginal cancer	0.0189	0.0189	CbGeAlD
Gefitinib—CHEK2—vagina—vaginal cancer	0.0188	0.0188	CbGeAlD
Gefitinib—EPHA6—female reproductive system—vaginal cancer	0.0186	0.0186	CbGeAlD
Gefitinib—EGFR—uterine cervix—vaginal cancer	0.0183	0.0183	CbGeAlD
Gefitinib—CSNK1E—uterine cervix—vaginal cancer	0.0176	0.0176	CbGeAlD
Gefitinib—IRAK4—uterine cervix—vaginal cancer	0.0173	0.0173	CbGeAlD
Gefitinib—ERBB3—epithelium—vaginal cancer	0.0171	0.0171	CbGeAlD
Gefitinib—ERBB3—uterine cervix—vaginal cancer	0.0169	0.0169	CbGeAlD
Gefitinib—MAP3K19—female reproductive system—vaginal cancer	0.0169	0.0169	CbGeAlD
Gefitinib—MKNK2—epithelium—vaginal cancer	0.0162	0.0162	CbGeAlD
Gefitinib—CSNK1E—urethra—vaginal cancer	0.0161	0.0161	CbGeAlD
Gefitinib—MKNK2—uterine cervix—vaginal cancer	0.0161	0.0161	CbGeAlD
Gefitinib—IRAK1—uterine cervix—vaginal cancer	0.0161	0.0161	CbGeAlD
Gefitinib—EGFR—mammalian vulva—vaginal cancer	0.016	0.016	CbGeAlD
Gefitinib—MKNK1—uterine cervix—vaginal cancer	0.0159	0.0159	CbGeAlD
Gefitinib—IRAK4—urethra—vaginal cancer	0.0159	0.0159	CbGeAlD
Gefitinib—CSNK1E—endometrium—vaginal cancer	0.0159	0.0159	CbGeAlD
Gefitinib—IRAK4—endometrium—vaginal cancer	0.0156	0.0156	CbGeAlD
Gefitinib—CSNK1E—mammalian vulva—vaginal cancer	0.0154	0.0154	CbGeAlD
Gefitinib—EGFR—uterus—vaginal cancer	0.0152	0.0152	CbGeAlD
Gefitinib—IRAK4—mammalian vulva—vaginal cancer	0.0151	0.0151	CbGeAlD
Gefitinib—MKNK2—urethra—vaginal cancer	0.0148	0.0148	CbGeAlD
Gefitinib—CSNK1E—uterus—vaginal cancer	0.0146	0.0146	CbGeAlD
Gefitinib—MKNK1—urethra—vaginal cancer	0.0146	0.0146	CbGeAlD
Gefitinib—MKNK2—endometrium—vaginal cancer	0.0146	0.0146	CbGeAlD
Gefitinib—MKNK1—endometrium—vaginal cancer	0.0144	0.0144	CbGeAlD
Gefitinib—ERBB3—uterus—vaginal cancer	0.0141	0.0141	CbGeAlD
Gefitinib—MKNK2—mammalian vulva—vaginal cancer	0.0141	0.0141	CbGeAlD
Gefitinib—IRAK1—mammalian vulva—vaginal cancer	0.0141	0.0141	CbGeAlD
Gefitinib—MKNK1—mammalian vulva—vaginal cancer	0.0139	0.0139	CbGeAlD
Gefitinib—MKNK2—uterus—vaginal cancer	0.0134	0.0134	CbGeAlD
Gefitinib—CSNK1E—female reproductive system—vaginal cancer	0.0132	0.0132	CbGeAlD
Gefitinib—STK10—uterine cervix—vaginal cancer	0.0131	0.0131	CbGeAlD
Gefitinib—ERBB3—female reproductive system—vaginal cancer	0.0127	0.0127	CbGeAlD
Gefitinib—EGFR—female gonad—vaginal cancer	0.0124	0.0124	CbGeAlD
Gefitinib—MKNK2—female reproductive system—vaginal cancer	0.0121	0.0121	CbGeAlD
Gefitinib—IRAK1—female reproductive system—vaginal cancer	0.0121	0.0121	CbGeAlD
Gefitinib—CSNK1E—female gonad—vaginal cancer	0.012	0.012	CbGeAlD
Gefitinib—MKNK1—female reproductive system—vaginal cancer	0.0119	0.0119	CbGeAlD
Gefitinib—CSNK1E—vagina—vaginal cancer	0.0119	0.0119	CbGeAlD
Gefitinib—IRAK4—female gonad—vaginal cancer	0.0118	0.0118	CbGeAlD
Gefitinib—IRAK4—vagina—vaginal cancer	0.0117	0.0117	CbGeAlD
Gefitinib—MAP2K5—uterine cervix—vaginal cancer	0.0117	0.0117	CbGeAlD
Gefitinib—ERBB3—female gonad—vaginal cancer	0.0115	0.0115	CbGeAlD
Gefitinib—STK10—mammalian vulva—vaginal cancer	0.0115	0.0115	CbGeAlD
Gefitinib—MKNK2—female gonad—vaginal cancer	0.011	0.011	CbGeAlD
Gefitinib—IRAK1—female gonad—vaginal cancer	0.011	0.011	CbGeAlD
Gefitinib—STK10—uterus—vaginal cancer	0.0109	0.0109	CbGeAlD
Gefitinib—MKNK2—vagina—vaginal cancer	0.0109	0.0109	CbGeAlD
Gefitinib—MKNK1—female gonad—vaginal cancer	0.0108	0.0108	CbGeAlD
Gefitinib—MKNK1—vagina—vaginal cancer	0.0108	0.0108	CbGeAlD
Gefitinib—MAP2K5—urethra—vaginal cancer	0.0107	0.0107	CbGeAlD
Gefitinib—MAP2K5—endometrium—vaginal cancer	0.0106	0.0106	CbGeAlD
Gefitinib—MAP2K5—mammalian vulva—vaginal cancer	0.0102	0.0102	CbGeAlD
Gefitinib—STK10—female reproductive system—vaginal cancer	0.00981	0.00981	CbGeAlD
Gefitinib—STK10—female gonad—vaginal cancer	0.00893	0.00893	CbGeAlD
Gefitinib—STK10—vagina—vaginal cancer	0.00887	0.00887	CbGeAlD
Gefitinib—MAP2K5—female reproductive system—vaginal cancer	0.00876	0.00876	CbGeAlD
Gefitinib—ORM1—endometrium—vaginal cancer	0.00859	0.00859	CbGeAlD
Gefitinib—MAP2K5—female gonad—vaginal cancer	0.00797	0.00797	CbGeAlD
Gefitinib—MAP2K5—vagina—vaginal cancer	0.00792	0.00792	CbGeAlD
Gefitinib—ORM1—female reproductive system—vaginal cancer	0.00711	0.00711	CbGeAlD
Gefitinib—ABCG2—uterine cervix—vaginal cancer	0.00569	0.00569	CbGeAlD
Gefitinib—CYP1A1—epithelium—vaginal cancer	0.00545	0.00545	CbGeAlD
Gefitinib—CYP1A1—uterine cervix—vaginal cancer	0.0054	0.0054	CbGeAlD
Gefitinib—CYP3A5—uterine cervix—vaginal cancer	0.00528	0.00528	CbGeAlD
Gefitinib—ABCG2—urethra—vaginal cancer	0.00523	0.00523	CbGeAlD
Gefitinib—ABCG2—endometrium—vaginal cancer	0.00515	0.00515	CbGeAlD
Gefitinib—ABCG2—mammalian vulva—vaginal cancer	0.00498	0.00498	CbGeAlD
Gefitinib—CYP1A1—urethra—vaginal cancer	0.00496	0.00496	CbGeAlD
Gefitinib—ABCG2—uterus—vaginal cancer	0.00474	0.00474	CbGeAlD
Gefitinib—CYP1A1—mammalian vulva—vaginal cancer	0.00473	0.00473	CbGeAlD
Gefitinib—CYP2C19—vagina—vaginal cancer	0.00454	0.00454	CbGeAlD
Gefitinib—CYP1A1—uterus—vaginal cancer	0.0045	0.0045	CbGeAlD
Gefitinib—CYP1A1—female reproductive system—vaginal cancer	0.00405	0.00405	CbGeAlD
Gefitinib—CYP2C9—female reproductive system—vaginal cancer	0.00389	0.00389	CbGeAlD
Gefitinib—ABCG2—female gonad—vaginal cancer	0.00388	0.00388	CbGeAlD
Gefitinib—ABCG2—vagina—vaginal cancer	0.00386	0.00386	CbGeAlD
Gefitinib—CYP1A1—female gonad—vaginal cancer	0.00368	0.00368	CbGeAlD
Gefitinib—CYP1A1—vagina—vaginal cancer	0.00366	0.00366	CbGeAlD
Gefitinib—CYP3A5—female gonad—vaginal cancer	0.0036	0.0036	CbGeAlD
Gefitinib—CYP3A5—vagina—vaginal cancer	0.00358	0.00358	CbGeAlD
Gefitinib—CYP3A4—female reproductive system—vaginal cancer	0.00297	0.00297	CbGeAlD
Gefitinib—CYP2D6—female reproductive system—vaginal cancer	0.00292	0.00292	CbGeAlD
Gefitinib—ABCB1—epithelium—vaginal cancer	0.00283	0.00283	CbGeAlD
Gefitinib—ABCB1—uterine cervix—vaginal cancer	0.00281	0.00281	CbGeAlD
Gefitinib—CYP2D6—female gonad—vaginal cancer	0.00266	0.00266	CbGeAlD
Gefitinib—ABCB1—urethra—vaginal cancer	0.00258	0.00258	CbGeAlD
Gefitinib—ABCB1—endometrium—vaginal cancer	0.00254	0.00254	CbGeAlD
Gefitinib—ABCB1—mammalian vulva—vaginal cancer	0.00245	0.00245	CbGeAlD
Gefitinib—ABCB1—uterus—vaginal cancer	0.00234	0.00234	CbGeAlD
Gefitinib—ABCB1—female reproductive system—vaginal cancer	0.0021	0.0021	CbGeAlD
Gefitinib—ABCB1—female gonad—vaginal cancer	0.00191	0.00191	CbGeAlD
Gefitinib—ABCB1—vagina—vaginal cancer	0.0019	0.0019	CbGeAlD
